Roux-en-Y gastric bypass, Nesidioblastosis and diabetes mellitus.
Ryan
John J
JJ
D000818:Animals; D049109:Cell Proliferation; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000628:therapy*; D015390:Gastric Bypass; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism / Q000502:physiology; D006801:Humans; D006946:Hyperinsulinism / Q000453:epidemiology / Q000209:etiology; D006965:Hyperplasia; D006984:Hypertrophy; D007003:Hypoglycemia / Q000453:epidemiology / Q000209:etiology; D015994:Incidence; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D050417:Insulin-Secreting Cells / Q000166:cytology / Q000473:pathology; D046768:Nesidioblastosis / Q000453:epidemiology / Q000209:etiology; D009767:Obesity, Morbid / Q000453:epidemiology / Q000601:surgery; D011183:Postoperative Complications; D051381:Rats
D007328:Insulin; D052216:Glucagon-Like Peptide 1